










Increasing prevalence of asthma, allergic rhinoconjunctivitis and eczema among 
schoolchildren: Three surveys during the period1985-2008. 
 
Author’s names and institutional affiliations: 
1. Tonje Elisabeth Hansen, MD 
Division of Pediatrics, Obstetrics and Woman’s Health, Nordland Hospital, Bodø, 
Norway  
2. Bjørg Evjenth, MD  
Division of Pediatrics, Obstetrics and Woman’s Health, Nordland Hospital, Bodø, 
Norway  
3. Jan Holt MD, PhD  
a) Division of Pediatrics, Obstetrics and Woman’s Health, Nordland Hospital, Bodø, 
Norway 
b) Institute of Community Medicine, University of Tromsø, Tromsø, Norway 
 
Short title:  
Asthma, allergic rhinoconjunctivitis and eczema prevalence in 
schoolchildren in a subarctic population. 
Corresponding author: Tonje Elisabeth Hansen 
Division of Pediatrics, Obstetrics and Woman’s Health, Nordland hospital, Post box 
1480, 8092 Bodø, Norway,  






TEH: Designed the study, collected data, analyzed data and wrote the 
article. 
BE: Analyzed data and wrote the article. 
JH: Designed the study analyzed data and revised the article critically. 
 
Conflict of interests 
The authors declare no conflicts of interest in respect to the authorship and/or 









Aim: The prevalence of asthma, allergic rhinoconjunctivitis (AR) and eczema among 
children has increased worldwide in the last four decades, but recent studies disagree 
as to whether the prevalence is continuing to rise or is leveling off or declining. The 
aim of this study was to assess time trends in a subarctic population. 
Methods: A cross-sectional, questionnaire-based survey was carried out in 2008 
among children aged 7-14 years in random selected schools in Nordland County, 
Norway (n=4150).  The results are compared with results from identical studies in 
1985 (n=4870) and 1995 (n=4456). 
Results: The main findings were an increasing prevalence of asthma ever (7.3% in 
1985 to 17.6% in 2008, p for trend < 0.001) and AR ever (15.9% in 1985 to 24.5% in 
2008, p for trend < 0.001), while the prevalence of eczema ever, after an increase 
between 1985 and 1995, remained unchanged in the last time period. The prevalence 
of current disease doubled and trebled between 1995 and 2008 for all three diseases.  
Conclusion: A repeated cross-sectional survey between 1985-2008 documented an 
increasing prevalence of asthma ever and AR ever among schoolchildren (7-14 












Repeated cross-sectional surveys between 1985-2008 demonstrated an increase in the 
prevalence of asthma and allergic rhinoconjunctivitis ever among school children (7-
14 years) in a subarctic population, while the prevalence of eczema ever leveled off. 








In recent decades the prevalence of asthma and allergic diseases has increased 
substantially, and today asthma is the most frequent chronic disease among children 
in developed countries (1). This imposes a considerable burden of disease on 
patients, health care systems and society. Whereas some studies still demonstrate an 
increasing prevalence of asthma and allergic disease (2-4), other reports indicate a 
leveling off or even a decrease in the prevalence (5-7). Results from the ISAAC 
phase III study (2000-2003) indicate that the difference in asthma symptom 
prevalence between developed and developing countries has fallen (8). In spite of 
this change, the prevalence of asthma, allergic rhinoconjunctivitis (AR) and eczema 
shows wide global variation (9). The diverse global trends make regional repeated 
investigations important to assess time trends. Local surveys provide information 
about geoclimatic variables and topographical factors that may affect disease 
prevalence (10). In the northern part of Norway a questionnaire-based, cross-
sectional survey of asthma and allergic disease was performed in 1985 (11) and 
repeated 10 years later: The lifetime prevalence of asthma and allergic diseases 
increased over this period (12). Thus, the objective of the current study was to 
explore whether or not the prevalence of asthma, AR and eczema continued to 
increase in a population of children in a subarctic area. 
 
Subjects and Methods 
 
Study area 
The Northern part of Norway consists of three counties: Nordland, Troms and 




which covers an area of 37000 km2, has a unique geography with a long coastline, 
half of it located north of the Arctic Circle. The subarctic climate in Nordland 
displays an average yearly temperature of 5-6 degrees Celsius and a yearly amount of 
precipitation (rainfall) of 3000 millimeters. 
 
The questionnaire 
A questionnaire focusing on diagnosis and symptoms of asthma, AR and eczema was 
created in 1985 to assess disease among schoolchildren in northern Norway. 
Questions covered gender, age, family history of atopy, socio-economic conditions, 
passive smoke exposure and household animals. The questionnaire was completed by 
parents/guardians who also signed a written consent for their children’s participation. 
The questionnaire has been used in other Norwegian studies (14,15), and its validity 
has been evaluated. The questionnaire-based diagnosis of asthma was found to have 
a sensitivity of 0.96 and a specificity of 0.88 (14).   
 
The 1985 and 1995 studies 
The questionnaire was distributed to schoolchildren aged 7-13 years in randomly 
selected schools in northern Norway in 1985 and 1995. The local school nurse 
distributed the questionnaires and passed a new questionnaire to those not 
responding. The questionnaires were completed by 95% in 1985 and by 87% in 
1995. The 1995 study included additional questions concerning symptoms and 
diseases during the last 12 months (current diseases), but was otherwise identical. 




The 2008 study 
In 2008, we used identical questions to those used before adding questions about 
physical activity, medical diagnose of asthma and asthma medication. The additional 
questions did not change the definition of the diseases. Schoolchildren aged 7-14 
years from 65 randomly selected schools out of a totally 244 schools in Nordland 
County were invited to participate. These 65 schools represent 31 of 44 
municipalities (local authorities) in the County. The pupils received the questionnaire 
between February and May.  This time we were not allowed from the Regional 
Committee for Medical and Healthcare Research to send personal reminders. Thus 
all participants received one reminder. The study closed four weeks after the 
reminder was distributed. 
 
Definitions 
'Asthma ever' was considered if the parent answered 'yes' to the question: Has the 
pupil ever had asthma (question 1)? and/or to the question: Does the pupil 
experience wheeze, periods of coughing or acute shortness of breath (asthma) due to 
external factors (question 2)?  
Allergic Rhinoconjunctivitis (AR) ever  was estimated on the basis of a positive 
answer to the question:  Has the pupil ever had hay fever (runny or blocked nose, 
sneezing, itching of the nose and/or eyes, or swollen or red eyes)?  
Eczema ever was recorded if the pupils reported an itchy rash lasting at least four 
weeks combined with lesions on the face, elbows or knee flexures, or a high degree 




Current disease was considered among those answering yes to the main questions 
about asthma, AR or eczema and reporting symptoms the last 12 months. 
Atopic disease among family members was defined when answering yes to the 
question:  Does anyone in the family suffer from asthma, hay fever, eczema, urticaria 
or other diseases you believe are caused by allergy? The answers specified which 




The main outcome was differences in prevalence between the periods 1985-95 and 
1995-2008. The analyses were performed using chi-square statistics, and the 
differences in secular prevalence were quantified with odds ratios (OR). For values 
measured three times, chi-square test for trend (linear-by-linear associations) was 
calculated. P-values below 0.05 were considered statistically significant in all 
analyses, and they were accompanied by a 95% confidence interval (95% CI). Only a 
few missing values to the main questions about asthma, AR and eczema (0.3%, 1.0% 
and 0.7% respectively) were found. The missing values were considered to be non-
confirmative. The statistical analyses were performed using Graph Pad Prism version 
5 (Graphial Software, San Diego Ca, USA) and Statistical Package for Social 




The study protocol was approved by the Regional Committee for Medical and 





Of 6505 pupils invited to participate, 4150 (64%) were enrolled in the study (49.1% 
boys). The demographic data of all three surveys are given in Table 1.  
 
Asthma 
The prevalence of asthma ever increased from 7.3% in 1985 to 17.6% in 2008 (p for 
trend < 0.001) (Table 2). The prevalence of asthma ever was significantly higher 
among boys compared to girls in all three surveys: In 1985 8.9% vs. 5.5% (OR 1.68, 
95% CI: 1.34-2.10), in 1995 14.5% vs. 10.3% (OR 1.48; 1.23-1.77) and in 2008 
21.4% vs. 13.9% (OR 1.68; 1.43-1.98). Current asthma increased from 4.8% to 9.9% 
between 1995 and 2008 (Table 3). In 2008 doctor diagnosed asthma ever was 
reported by 13.8% of the participants, asthma medication ever by 18.5% and asthma 
medication used the last year by 8.2% of the participants. 
 
Allergic rhinoconjunctivitis (AR)  
The prevalence of AR ever increased between 1985 and 2008 (p for trend < 0.001) 
(Table 2). The prevalence of AR ever was significantly higher among boys compared 
to girls in all three surveys: In 1985 18.2% vs. 13.4% (OR 1.43; 1.23-1.68), in 1995 
24.6% vs. 18.3% (OR 1.48; 1.28-1.71) and in 2008 27.9% vs. 21.2% (OR 1.43; 1.24-






The prevalence of eczema ever increased in the first time period and remained 
unchanged in the last period (Table 2). The prevalence of eczema ever was 
approximately similar between girls and boys in 1985 (12.8% vs. 11.7%, OR 1.1; 
0.93-1.32), but higher among girls in 1995 and 2008 (OR 1.43; 1.23-1.68 and OR 
1.48; 1.28-1.71, respectively). The prevalence of current eczema was more frequent 
in 2008 in both genders (Table 3).  
 
The atopic burden and potential confounding factors 
An increasing part of the responders reported a family history of atopy, parental 
asthma and parental allergy (Table 1). In 1985 21.8% of the children reporting atopic 
disease in the family had asthma, AR and/or eczema. This proportion increased to 
50.6% in 2008 (p for trend < 0.001). Passive smoke exposure decreased from 60.7% 
to 31.9% (p for trend < 0.001), while the number of households keeping pet animals 
remained unchanged (56.3% in 1985 vs. 56.0% in 2008). 
 
Co-morbidity  
The proportion of children reporting at least one disease (asthma, AR or eczema) 
increased from 26.2% in 1985 to 43.3% in 2008 (p for trend < 0.001). The proportion 
of children with all three diseases and the proportion of children with both asthma 
and eczema increased during the study period (Table 4). The proportion of children 
reporting the combination of asthma and AR or AR and eczema increased in the first 






The main findings in the present study were an increasing prevalence of asthma ever 
and AR ever, while the prevalence of eczema ever, after increasing between 1985 
and 1995, stayed unchanged in the last time period. The prevalence rates found in 
2008 are similar to those shown in the Norwegian birth cohort study, Oslo (2), but 
somewhat higher compared to results in the OLIN studies (Obstructive Lung Disease 
in northern Sweden) (16,17). In spite of an increasing prevalence of asthma ever, 
data from the last time period indicated a peak in asthma symptoms. The divergent 
prevalence of asthma symptoms and asthma diagnosis are consistent with data from 
other Nordic reports (7,18). In contrast to several prevalence studies in comparable 
populations (2,9,19) we demonstrated a substantial increase in the proportion of 
children reporting current diseases in the last time period.  
 
Atopic disease in the family is an important risk factor for developing asthma, AR 
and/or eczema (16,20,21). Increased atopic burden among family members is 
evident. Two-thirds of the children in the 2008 survey had parents and/or siblings 
with atopic diseases, along with a doubling of parental asthma and allergy between 
1985 and 2008. The proportion of children suffering from asthma, AR and/or eczema 
confirming atopic disease in the family more than doubled during the study period. 
Asthma, AR and eczema are closely related (2,22). Still we found a leveling off in 
the co-morbidity of asthma and AR, while the co-morbidity of asthma and eczema 
increased. This pattern is in line with the findings in a recent report from the ISAAC 




Male gender is a risk factor for asthma and allergy among children (7,24). We 
detected a male predominance, which is in line with the results found by 
Anthracopoulos et al. (25). Whereas the results for asthma and AR revealed a male 
dominance through the study period, the results for eczema demonstrated a higher 
proportion of girls in the last two surveys. A study from Larsson et al. (21) supports 
these findings. Thus the unchanged prevalence of eczema ever in the last time period 
might be due to an unchanged prevalence in girls.  
 
Local environmental factors might be important contributors to different disease 
prevalence (9). Passive smoke exposure decreased sizeable from 1985 to 2008. Since 
second hand smoke exposure is associated with both the development of asthma and 
more severe disease, the decrease might be expected to lower the prevalence of 
asthma (26). Most of the study population lives in a cold, coastal climate. During 
wintertime the amount of indoor time is higher in a subarctic population. Weiland 
and colleges have proposed a negative effect of the annual variation of temperature 
and relative humidity outdoors on asthma and eczema symptoms (27).  
 
The use of identical study design and questionnaires in three surveys has allowed us 
to assess a valid estimate of time trends for self-reported atopic diseases. The 
reliability of the results of studies based on questionnaires can be questioned. 
However self-reported symptom history conducts the necessary basis for defining 
asthma in epidemiological studies (10,28). Repeated surveys in the same population 
are as close a proxy, as it was possible to attain of longitudinal data. In contrast to the 




which formed the basis of more valid time trends. Still the time interval between the 
last two surveys might have been too long to detect a plateau in disease prevalence. 
Thus, the need of follow-up surveys in due time is evident. Questions about current 
symptoms are more reliable than questions about symptoms ever due to less recall 
bias and might give a better estimate of time trends. The proportions of children 
reporting use of asthma medication ever and last year are not different from the 
prevalence of asthma ever and current asthma, which strengthen the results.  
 
Allergic diseases are given significant public health and media attention in Western 
societies. The impact of increased general awareness has been proposed in several 
papers to explain the increasing trend in the prevalence of allergic diseases (10). 
Increased awareness among health professionals and parents might have influenced 
the time trends in our study, and the increased atopic burden might represent a 
selection bias. Parents suffering from these diseases are expected to be more positive 
to participate and to be more aware of symptoms and diseases. Thus it is a possibility 
that the increase in heredity and disease prevalence might partly be due to this 
selection bias. The response rate of 64 % in 2008 is lower than in the previous 
surveys, and might entail a potential selection bias. In 2008 we were not allowed to 
give personal reminders to the participants. We believe this represent the main cause 
of the lower response rate compared to the earlier surveys. It was not possible to 
perform any analysis of the non-responders. However a large postal survey in 
Sweden by Rönmark et al concluded that non-responders did not differ significantly 
in the prevalence of airway diseases or symptoms compared with responders (29). 




a large, representative fraction of the population from randomly selected schools in 
Nordland we believe the external validity of our study to be high. 
 
In conclusion the prevalence of asthma ever and AR ever in a subarctic children 
population increased substantially between 1985 to 2008, while the prevalence of 
eczema ever reached a plateau. The doubling and tripling of current asthma, eczema 
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